Plasma Cystatin C and Acute Kidney Injury
Use of Cystatin C in Predicting AKI in Patients Undergone Cardiopulmonary Bypass Surgery
Sponsor: Jinhua Central Hospital
A observational or N/A phase clinical study on Acute Kidney Injury, this trial is ongoing. The trial is conducted by Jinhua Central Hospital and has accumulated 6 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status
-
Apr 2018 — Jun 2018 [monthly]
Unknown Status
Phase: NA → None
▶ Show 1 earlier version
-
Jan 2017 — Apr 2018 [monthly]
Unknown Status NA
First recorded
Apr 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Jinhua Central Hospital
For direct contact, visit the study record on ClinicalTrials.gov .